(19)
(11) EP 4 572 748 A1

(12)

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23855393.7

(22) Date of filing: 15.08.2023
(51) International Patent Classification (IPC): 
A61K 31/015(2006.01)
A61K 31/03(2006.01)
G01T 1/00(2006.01)
A61K 31/195(2006.01)
A61K 31/18(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/5375; A61K 31/166; A61K 31/167
(86) International application number:
PCT/US2023/030238
(87) International publication number:
WO 2024/039653 (22.02.2024 Gazette 2024/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 16.08.2022 US 202263398480 P

(71) Applicant: NEUROPRO THERAPEUTICS, INC.
Yachats, OR 97498 (US)

(72) Inventor:
  • HOCHMAN, Daryl W.
    Yachats, Oregon 97498 (US)

(74) Representative: Viluma, Johanna Estere 
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) THERAPEUTIC COMPOSITION, METHODS, AND USES FOR THE CONTROL OF SEIZURES